CN105816850A - 一种防疲劳提神的复合制剂及其制备工艺 - Google Patents
一种防疲劳提神的复合制剂及其制备工艺 Download PDFInfo
- Publication number
- CN105816850A CN105816850A CN201610224563.8A CN201610224563A CN105816850A CN 105816850 A CN105816850 A CN 105816850A CN 201610224563 A CN201610224563 A CN 201610224563A CN 105816850 A CN105816850 A CN 105816850A
- Authority
- CN
- China
- Prior art keywords
- extract
- fatigue
- caffeine
- pers
- bull
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 238000002360 preparation method Methods 0.000 title claims abstract description 23
- 150000001875 compounds Chemical class 0.000 title claims abstract description 21
- RYYVLZVUVIJVGH-UHFFFAOYSA-N caffeine Chemical compound CN1C(=O)N(C)C(=O)C2=C1N=CN2C RYYVLZVUVIJVGH-UHFFFAOYSA-N 0.000 claims abstract description 68
- 239000000284 extract Substances 0.000 claims abstract description 36
- LPHGQDQBBGAPDZ-UHFFFAOYSA-N Isocaffeine Natural products CN1C(=O)N(C)C(=O)C2=C1N(C)C=N2 LPHGQDQBBGAPDZ-UHFFFAOYSA-N 0.000 claims abstract description 34
- 229960001948 caffeine Drugs 0.000 claims abstract description 34
- VJEONQKOZGKCAK-UHFFFAOYSA-N caffeine Natural products CN1C(=O)N(C)C(=O)C2=C1C=CN2C VJEONQKOZGKCAK-UHFFFAOYSA-N 0.000 claims abstract description 34
- 240000000588 Hericium erinaceus Species 0.000 claims abstract description 32
- 235000007328 Hericium erinaceus Nutrition 0.000 claims abstract description 32
- 244000068988 Glycine max Species 0.000 claims abstract description 23
- 235000010469 Glycine max Nutrition 0.000 claims abstract description 23
- 229920001184 polypeptide Polymers 0.000 claims abstract description 23
- 102000004196 processed proteins & peptides Human genes 0.000 claims abstract description 23
- 108090000765 processed proteins & peptides Proteins 0.000 claims abstract description 23
- 235000020710 ginseng extract Nutrition 0.000 claims abstract description 20
- 239000008187 granular material Substances 0.000 claims description 45
- 239000000203 mixture Substances 0.000 claims description 34
- 244000309464 bull Species 0.000 claims description 31
- 238000009835 boiling Methods 0.000 claims description 22
- 230000002929 anti-fatigue Effects 0.000 claims description 19
- 238000009472 formulation Methods 0.000 claims description 19
- 239000000843 powder Substances 0.000 claims description 16
- 238000004806 packaging method and process Methods 0.000 claims description 15
- NOOLISFMXDJSKH-UHFFFAOYSA-N p-menthan-3-ol Chemical compound CC(C)C1CCC(C)CC1O NOOLISFMXDJSKH-UHFFFAOYSA-N 0.000 claims description 11
- 238000010438 heat treatment Methods 0.000 claims description 10
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 10
- ODINCKMPIJJUCX-UHFFFAOYSA-N Calcium oxide Chemical compound [Ca]=O ODINCKMPIJJUCX-UHFFFAOYSA-N 0.000 claims description 9
- 238000005516 engineering process Methods 0.000 claims description 9
- 238000001704 evaporation Methods 0.000 claims description 9
- 239000002994 raw material Substances 0.000 claims description 7
- 238000001914 filtration Methods 0.000 claims description 6
- 229920000742 Cotton Polymers 0.000 claims description 5
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 5
- 241000533293 Sesbania emerus Species 0.000 claims description 5
- 239000013078 crystal Substances 0.000 claims description 5
- 238000007598 dipping method Methods 0.000 claims description 5
- 239000006185 dispersion Substances 0.000 claims description 5
- 238000001035 drying Methods 0.000 claims description 5
- 238000000605 extraction Methods 0.000 claims description 5
- 239000000706 filtrate Substances 0.000 claims description 5
- 239000012530 fluid Substances 0.000 claims description 5
- 238000005469 granulation Methods 0.000 claims description 5
- 230000003179 granulation Effects 0.000 claims description 5
- 238000007654 immersion Methods 0.000 claims description 5
- 239000000463 material Substances 0.000 claims description 5
- 239000006228 supernatant Substances 0.000 claims description 5
- 241000195633 Dunaliella salina Species 0.000 claims description 2
- 150000004676 glycans Chemical class 0.000 claims description 2
- 229920001282 polysaccharide Polymers 0.000 claims description 2
- 239000005017 polysaccharide Substances 0.000 claims description 2
- 238000000034 method Methods 0.000 claims 1
- 239000003814 drug Substances 0.000 abstract description 15
- 230000036541 health Effects 0.000 abstract description 6
- 238000002474 experimental method Methods 0.000 abstract description 3
- 229940105902 mint extract Drugs 0.000 abstract 1
- 230000002688 persistence Effects 0.000 abstract 1
- 230000000694 effects Effects 0.000 description 24
- 206010016256 fatigue Diseases 0.000 description 17
- 230000003340 mental effect Effects 0.000 description 9
- 210000004556 brain Anatomy 0.000 description 8
- 210000002784 stomach Anatomy 0.000 description 6
- 230000006870 function Effects 0.000 description 5
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 4
- 239000000292 calcium oxide Substances 0.000 description 4
- 235000012255 calcium oxide Nutrition 0.000 description 4
- 230000029087 digestion Effects 0.000 description 4
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 description 4
- 150000003254 radicals Chemical class 0.000 description 4
- 210000001835 viscera Anatomy 0.000 description 4
- 241000208340 Araliaceae Species 0.000 description 3
- 235000005035 Panax pseudoginseng ssp. pseudoginseng Nutrition 0.000 description 3
- 235000003140 Panax quinquefolius Nutrition 0.000 description 3
- 201000010099 disease Diseases 0.000 description 3
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 3
- 238000011049 filling Methods 0.000 description 3
- 235000013305 food Nutrition 0.000 description 3
- 235000008434 ginseng Nutrition 0.000 description 3
- 230000036039 immunity Effects 0.000 description 3
- 230000004060 metabolic process Effects 0.000 description 3
- 210000003205 muscle Anatomy 0.000 description 3
- 238000011084 recovery Methods 0.000 description 3
- 240000002853 Nelumbo nucifera Species 0.000 description 2
- 235000006508 Nelumbo nucifera Nutrition 0.000 description 2
- 235000006510 Nelumbo pentapetala Nutrition 0.000 description 2
- 208000007443 Neurasthenia Diseases 0.000 description 2
- 244000269722 Thea sinensis Species 0.000 description 2
- 239000002253 acid Substances 0.000 description 2
- 206010003549 asthenia Diseases 0.000 description 2
- 230000009286 beneficial effect Effects 0.000 description 2
- 230000033228 biological regulation Effects 0.000 description 2
- 210000003169 central nervous system Anatomy 0.000 description 2
- 235000009508 confectionery Nutrition 0.000 description 2
- 230000037149 energy metabolism Effects 0.000 description 2
- 230000003203 everyday effect Effects 0.000 description 2
- 230000005284 excitation Effects 0.000 description 2
- 229940089161 ginsenoside Drugs 0.000 description 2
- 229930182494 ginsenoside Natural products 0.000 description 2
- 235000013402 health food Nutrition 0.000 description 2
- 239000004310 lactic acid Substances 0.000 description 2
- 235000014655 lactic acid Nutrition 0.000 description 2
- 210000005036 nerve Anatomy 0.000 description 2
- 235000015097 nutrients Nutrition 0.000 description 2
- 230000003647 oxidation Effects 0.000 description 2
- 238000007254 oxidation reaction Methods 0.000 description 2
- LXNHXLLTXMVWPM-UHFFFAOYSA-N pyridoxine Chemical compound CC1=NC=C(CO)C(CO)=C1O LXNHXLLTXMVWPM-UHFFFAOYSA-N 0.000 description 2
- 230000000391 smoking effect Effects 0.000 description 2
- 239000013589 supplement Substances 0.000 description 2
- XOAAWQZATWQOTB-UHFFFAOYSA-N taurine Chemical compound NCCS(O)(=O)=O XOAAWQZATWQOTB-UHFFFAOYSA-N 0.000 description 2
- -1 xanthine alkaloid compound Chemical class 0.000 description 2
- 208000024827 Alzheimer disease Diseases 0.000 description 1
- 206010002091 Anaesthesia Diseases 0.000 description 1
- 241000283690 Bos taurus Species 0.000 description 1
- 208000017897 Carcinoma of esophagus Diseases 0.000 description 1
- 206010012735 Diarrhoea Diseases 0.000 description 1
- 208000010228 Erectile Dysfunction Diseases 0.000 description 1
- 229920002527 Glycogen Polymers 0.000 description 1
- SQUHHTBVTRBESD-UHFFFAOYSA-N Hexa-Ac-myo-Inositol Natural products CC(=O)OC1C(OC(C)=O)C(OC(C)=O)C(OC(C)=O)C(OC(C)=O)C1OC(C)=O SQUHHTBVTRBESD-UHFFFAOYSA-N 0.000 description 1
- 206010061218 Inflammation Diseases 0.000 description 1
- KDXKERNSBIXSRK-YFKPBYRVSA-N L-lysine Chemical compound NCCCC[C@H](N)C(O)=O KDXKERNSBIXSRK-YFKPBYRVSA-N 0.000 description 1
- KDXKERNSBIXSRK-UHFFFAOYSA-N Lysine Natural products NCCCCC(N)C(O)=O KDXKERNSBIXSRK-UHFFFAOYSA-N 0.000 description 1
- 239000004472 Lysine Substances 0.000 description 1
- 102000036675 Myoglobin Human genes 0.000 description 1
- 108010062374 Myoglobin Proteins 0.000 description 1
- 206010030155 Oesophageal carcinoma Diseases 0.000 description 1
- 229910019142 PO4 Inorganic materials 0.000 description 1
- QFJUYMMIBFBOJY-UXZRXANASA-N Panaxatriol Chemical compound C[C@]1([C@H]2CC[C@@]3([C@@H]2[C@H](O)C[C@H]2[C@]3(C[C@@H](O)[C@H]3C(C)(C)[C@@H](O)CC[C@@]32C)C)C)CCCC(C)(C)O1 QFJUYMMIBFBOJY-UXZRXANASA-N 0.000 description 1
- VIXIMKLMEZTTTC-UHFFFAOYSA-N Panaxatriol Natural products CC1(C)CCCC(O1)C2CCC3(C)C2C(O)CC4C5(C)CCC(O)C(C)(C)C5C(O)CC34C VIXIMKLMEZTTTC-UHFFFAOYSA-N 0.000 description 1
- 241000282376 Panthera tigris Species 0.000 description 1
- 239000004743 Polypropylene Substances 0.000 description 1
- 206010039966 Senile dementia Diseases 0.000 description 1
- 208000013738 Sleep Initiation and Maintenance disease Diseases 0.000 description 1
- 208000032140 Sleepiness Diseases 0.000 description 1
- 206010041349 Somnolence Diseases 0.000 description 1
- 208000005718 Stomach Neoplasms Diseases 0.000 description 1
- 208000007107 Stomach Ulcer Diseases 0.000 description 1
- 229930006000 Sucrose Natural products 0.000 description 1
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 1
- XSTXAVWGXDQKEL-UHFFFAOYSA-N Trichloroethylene Chemical compound ClC=C(Cl)Cl XSTXAVWGXDQKEL-UHFFFAOYSA-N 0.000 description 1
- 229930003779 Vitamin B12 Natural products 0.000 description 1
- 208000027418 Wounds and injury Diseases 0.000 description 1
- 206010000059 abdominal discomfort Diseases 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 230000032683 aging Effects 0.000 description 1
- 230000037005 anaesthesia Effects 0.000 description 1
- 230000003712 anti-aging effect Effects 0.000 description 1
- 230000001093 anti-cancer Effects 0.000 description 1
- 230000003064 anti-oxidating effect Effects 0.000 description 1
- 206010064097 avian influenza Diseases 0.000 description 1
- 210000001124 body fluid Anatomy 0.000 description 1
- 239000010839 body fluid Substances 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- FDJOLVPMNUYSCM-WZHZPDAFSA-L cobalt(3+);[(2r,3s,4r,5s)-5-(5,6-dimethylbenzimidazol-1-yl)-4-hydroxy-2-(hydroxymethyl)oxolan-3-yl] [(2r)-1-[3-[(1r,2r,3r,4z,7s,9z,12s,13s,14z,17s,18s,19r)-2,13,18-tris(2-amino-2-oxoethyl)-7,12,17-tris(3-amino-3-oxopropyl)-3,5,8,8,13,15,18,19-octamethyl-2 Chemical compound [Co+3].N#[C-].N([C@@H]([C@]1(C)[N-]\C([C@H]([C@@]1(CC(N)=O)C)CCC(N)=O)=C(\C)/C1=N/C([C@H]([C@@]1(CC(N)=O)C)CCC(N)=O)=C\C1=N\C([C@H](C1(C)C)CCC(N)=O)=C/1C)[C@@H]2CC(N)=O)=C\1[C@]2(C)CCC(=O)NC[C@@H](C)OP([O-])(=O)O[C@H]1[C@@H](O)[C@@H](N2C3=CC(C)=C(C)C=C3N=C2)O[C@@H]1CO FDJOLVPMNUYSCM-WZHZPDAFSA-L 0.000 description 1
- 239000012141 concentrate Substances 0.000 description 1
- 238000010276 construction Methods 0.000 description 1
- 210000003792 cranial nerve Anatomy 0.000 description 1
- 230000006378 damage Effects 0.000 description 1
- 230000018109 developmental process Effects 0.000 description 1
- 238000004821 distillation Methods 0.000 description 1
- 208000002173 dizziness Diseases 0.000 description 1
- 230000035622 drinking Effects 0.000 description 1
- 208000000718 duodenal ulcer Diseases 0.000 description 1
- 235000013399 edible fruits Nutrition 0.000 description 1
- 201000005619 esophageal carcinoma Diseases 0.000 description 1
- 238000007667 floating Methods 0.000 description 1
- 206010017758 gastric cancer Diseases 0.000 description 1
- 230000002496 gastric effect Effects 0.000 description 1
- 210000001035 gastrointestinal tract Anatomy 0.000 description 1
- 229940096919 glycogen Drugs 0.000 description 1
- 201000001881 impotence Diseases 0.000 description 1
- 206010022000 influenza Diseases 0.000 description 1
- 208000014674 injury Diseases 0.000 description 1
- CDAISMWEOUEBRE-GPIVLXJGSA-N inositol Chemical compound O[C@H]1[C@H](O)[C@@H](O)[C@H](O)[C@H](O)[C@@H]1O CDAISMWEOUEBRE-GPIVLXJGSA-N 0.000 description 1
- 229960000367 inositol Drugs 0.000 description 1
- 206010022437 insomnia Diseases 0.000 description 1
- 210000003734 kidney Anatomy 0.000 description 1
- 210000004185 liver Anatomy 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 210000004072 lung Anatomy 0.000 description 1
- 229960003646 lysine Drugs 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 235000012054 meals Nutrition 0.000 description 1
- 239000008267 milk Substances 0.000 description 1
- 235000013336 milk Nutrition 0.000 description 1
- 210000004080 milk Anatomy 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- 230000005709 nerve cell growth Effects 0.000 description 1
- 230000001537 neural effect Effects 0.000 description 1
- 235000016709 nutrition Nutrition 0.000 description 1
- 230000035764 nutrition Effects 0.000 description 1
- 239000010452 phosphate Substances 0.000 description 1
- 239000002574 poison Substances 0.000 description 1
- 231100000614 poison Toxicity 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- 239000000047 product Substances 0.000 description 1
- RADKZDMFGJYCBB-UHFFFAOYSA-N pyridoxal hydrochloride Natural products CC1=NC=C(CO)C(C=O)=C1O RADKZDMFGJYCBB-UHFFFAOYSA-N 0.000 description 1
- 238000010791 quenching Methods 0.000 description 1
- 230000008929 regeneration Effects 0.000 description 1
- 238000011069 regeneration method Methods 0.000 description 1
- 230000008439 repair process Effects 0.000 description 1
- CDAISMWEOUEBRE-UHFFFAOYSA-N scyllo-inosotol Natural products OC1C(O)C(O)C(O)C(O)C1O CDAISMWEOUEBRE-UHFFFAOYSA-N 0.000 description 1
- 230000035807 sensation Effects 0.000 description 1
- 230000037321 sleepiness Effects 0.000 description 1
- 239000000779 smoke Substances 0.000 description 1
- 210000000952 spleen Anatomy 0.000 description 1
- 238000010025 steaming Methods 0.000 description 1
- 201000011549 stomach cancer Diseases 0.000 description 1
- 238000005728 strengthening Methods 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 208000024891 symptom Diseases 0.000 description 1
- 229960003080 taurine Drugs 0.000 description 1
- 230000035922 thirst Effects 0.000 description 1
- 230000003867 tiredness Effects 0.000 description 1
- 208000016255 tiredness Diseases 0.000 description 1
- 230000001052 transient effect Effects 0.000 description 1
- 235000019163 vitamin B12 Nutrition 0.000 description 1
- 239000011715 vitamin B12 Substances 0.000 description 1
- 235000019158 vitamin B6 Nutrition 0.000 description 1
- 239000011726 vitamin B6 Substances 0.000 description 1
- 229940011671 vitamin b6 Drugs 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
- A61K31/52—Purines, e.g. adenine
- A61K31/522—Purines, e.g. adenine having oxo groups directly attached to the heterocyclic ring, e.g. hypoxanthine, guanine, acyclovir
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/06—Fungi, e.g. yeasts
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/25—Araliaceae (Ginseng family), e.g. ivy, aralia, schefflera or tetrapanax
- A61K36/258—Panax (ginseng)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/53—Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
- A61K36/534—Mentha (mint)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/01—Hydrolysed proteins; Derivatives thereof
- A61K38/011—Hydrolysed proteins; Derivatives thereof from plants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/30—Extraction of the material
- A61K2236/33—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones
- A61K2236/331—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones using water, e.g. cold water, infusion, tea, steam distillation or decoction
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/30—Extraction of the material
- A61K2236/39—Complex extraction schemes, e.g. fractionation or repeated extraction steps
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Mycology (AREA)
- Botany (AREA)
- Alternative & Traditional Medicine (AREA)
- Microbiology (AREA)
- Medical Informatics (AREA)
- Biotechnology (AREA)
- Molecular Biology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Immunology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Medicines Containing Plant Substances (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
本发明涉及保健品领域,具体的说是一种防疲劳提神的复合制剂及其制备工艺。一种防疲劳提神的复合制剂,按重量份数计它包括如下成分:咖啡因2‑4份;人参提取物5‑7份;薄荷提取物4‑6份;岩藻多糖10‑20份;大豆多肽5‑10份;猴头菇提取物3‑5份。本发明还提供一种防疲劳提神的复合制剂的制备工艺。经人体实验证明,本发明的药物能使人快速恢复体力,消除疲劳感,精神饱满,且持续性强。
Description
技术领域
本发明涉及保健品领域,具体的说是一种防疲劳提神的复合制剂及其制备工艺。
背景技术
随着生活节奏的加快,脑力劳动的增多,社会压力的变大,人们常常会感觉到疲劳。特别是一些长时间高强度的工作,经常需要靠咖啡或浓茶进行提神,男生甚至会选择抽烟。首先,抽烟有害身体健康,且普适性差,随着人们越来越注重身体健康,抽烟人士逐渐减少;第二,喝浓茶或咖啡等,提神效果不佳,且无抗疲劳效果,且饮用不便,如果过量饮用也会对人体造成一定的伤害。目前有一些功能性饮料,类似于红牛或乐虎等,其主要成分是维生素PP、维生素B6、维生素B12、牛磺酸、赖氨酸、肌醇、咖啡因,这些成分协同作用,一定程度上可以帮助饮用者消除疲劳、提神醒脑和补充体力,但是这只是短时间内提供人体所需的营养素,人体代谢后便失去其功效,同时,功能性饮料本身不具有保健功能。
发明专利《一种抗疲劳的保健食品》(公开号为CN1907061A)公开一种以人参皂苷、咖啡、茶叶、白糖、奶粉、薄荷油、薄荷脑为原料的抗疲劳的保健食品。但是,从说明书发明内容的第二段来看,这几种原料仅是提供了人体对抗疲劳和使人神经兴奋的营养物质,并未能从人体自身的条件去改善,即是治标不治本。同时,咖啡、茶叶、薄荷油和薄荷脑较刺激,长期服用对胃会造成负担,尤其是本身胃部不舒适的时候,服用此食品,胃会有较明显的不适感。
发明内容
根据上述不足之处,本发明的目的是提供一种改善人体自身状况的具有防疲劳提神的复合制剂及其制备工艺。
为实现上述目的,本发明的技术方案在于:一种防疲劳提神的复合制剂,按重量份数计它包括如下成分:咖啡因2-4份;人参提取物5-7份;薄荷提取物4-6份;岩藻多糖10-20份;大豆多肽5-10份;猴头菇提取物3-5份。
优选的是:所述的咖啡因其提取工艺如下:将咖啡豆在250℃下进行焙炒并粉碎,得到熟咖啡粉;取10-20g咖啡粉末加入到容器中,加入40-100ml95%乙醇溶液浸泡1-2小时;微波加热5-10分钟;将容器内上清液倒入盛有生石灰的蒸发皿中加热,不断搅拌至粉末状,在蒸发皿上盖上一张扎有小孔的滤纸,再在上面扣一个口上塞有棉花的漏斗进行加热,使咖啡因升华,在滤纸小孔周围的针状晶体即为咖啡因,进行收集备用。
优选的是:所述的薄荷提取物为薄荷油和薄荷脑。
优选的是:所述的盐藻多糖的分子量为1000以内。
优选的是:所述的大豆多肽的分子量为500-1000。
优选的是:所述猴头菇提取物的制备方法为:将干燥的猴头菇清洗干净控干水分,掰成小块,采用2倍重量40-60℃的温水恒温浸泡半小时;浸泡后加热至煮沸,煮20-30分钟后,过滤,取滤渣加入1倍猴头菇原始重量的水继续加热至煮沸,煮30-40分钟后,过滤,取两次滤液合并后继续加热至煮沸,并不断搅拌,制成流浸膏备用。
本发明还提供一种防疲劳提神的复合制剂的制备工艺,它包括如下步骤:
(1)物料预处理:将咖啡因、人参提取物、岩藻多糖和大豆多肽分别进行过筛,所述的筛子为80-100目;
(2)称量:按照配方所述的量称取每种原料的量并单独存放;
(3)制粒:现将咖啡因、人参提取物、岩藻多糖和大豆多肽移入高效湿法制粒机中混合均匀后,加入猴头菇提取物,再次混合均匀后加入薄荷提取物混合均匀,制成颗粒;
(4)干燥:将湿颗粒移入快速整粒机分散制粒,再移入干燥制粒机中干燥,直至颗粒烘干;
(5)整粒:将干颗粒采用快速整粒机整粒,分散成均匀的颗粒;
(6)压片:将颗粒采用压片设备进行压片;
(7)包装:采用自动包装机包装,并进行装盒后再装箱,入库保存。
本发明的有益效果在于:
咖啡因是一种黄嘌呤生物碱化合物,是一种中枢神经兴奋剂,能够暂时的驱走睡意并恢复精力,可以刺激脑部的中枢神经系统,延长脑部清醒的时间,使思路清晰、敏锐,且注意力较为集中,可提高工作及学习的效率。
薄荷油、薄荷脑味辛性凉,轻扬升浮、芳香通窍,功善疏散上焦风热,清头目。
人参味甘、微苦,性温。有大补元气、固脱、生津、安神、益智功能。人参二醇、人参三醇和各种人参皂甙有抗疲劳作用,其中人参三醇的作用比人参二醇强1倍以上。人参提取物能导致对糖元和高能磷酸化合物更经济的利用,增强乳酸、丙酮酸的代谢,通过有氧氧化,为肌肉活动及时提供能量。
岩藻多糖具有双向调节免疫力,清除自由基,抗衰老,抗菌消炎,消除胃肠系统紊乱,等功效。
大豆多肽易消化吸收性。它进入人体不需消化,可以直接吸收;促进能量代谢,促过度疲劳恢复精神、体力的效果;增加肌肉的耐力,促进肌红蛋白恢复;抗氧化作用,消除人体自由基,防止新的自由基形成,延缓人体退化、老化的过程。
猴头菇性平、味甘。利五脏,助消化;具有健胃,补虚,抗癌,益肾精之功效;主治食少便溏、胃及十二指肠溃疡、神经衰弱、食道癌、胃癌、眩晕、阳痿等病症。年老体弱者食用猴头菇,有滋补强身的作用。猴头菇对增强人体免疫力尤为突出,可提高人体对SARS,禽流感,流感等疾患的抵抗力,是预防上述疾病的理想新武器。猴头菇具有独特的消化道系统保护、调理和修复功能,可助消化、益肝脾,解饥解渴、消除宿毒等多重功效。猴头菇对神经衰弱、失眠有特效。可促进脑神经细胞生长和再生,对预防和治疗老年痴呆症有良好效果。是益寿抗衰的新型营养健脑食品。
本发明的组方中,咖啡因可以在短时间内刺激脑部的中枢神经系统,延长脑部清醒的时间,使思路清晰、反应敏锐,起到了提神的效果;辅以薄荷油和薄荷脑,可以消退脑部的混沌感,进一步使头脑清醒。人参提取物可以增强乳酸、丙酮酸的代谢,通过有氧氧化,为人体及时提供能量,起到了抗疲劳的效果,同时,人参提取物具有安神的作用,人体只有得到充分的休息,才能真正补充体力,真正的抗疲劳,人参提取物的益智的作用,也有助于在高强度,高脑力劳动的情况下补充脑补营养,为高效的工作或学习提供基础。另一方面,薄荷油和薄荷脑均为寒性,而人参性温,可以抵消薄荷油和薄荷脑的寒性,普适性更强。低分子量的大豆多肽易于人体吸收,可以迅速补充人体的能量,促进能量代谢,有助于过度疲劳时恢复精神、体力的效果,精神和体力的恢复也就进一步消除了疲劳感,也进一步起到了提神的作用。咖啡因和薄荷提取物刺激性较强,服用后对胃部会造成不适感,猴头菇利五脏,助消化,具有健胃的疗效,可以帮助改善胃部不适,同时人体以五脏为根本,五脏功能的健康有助于人体吸收营养,快速恢复体力。岩藻多糖具有双向调节免疫力,清除自由基,使人体健康强健,这也是有助于提高人体机能,进一步利于人体体能的恢复。
经人体实验证明,本发明的药物能使人快速恢复体力,消除疲劳感,精神饱满,且持续性强。
具体实施方式
下面结合具体实施例对本发明做进一步说明。
实施例1
一种防疲劳提神的复合制剂,按重量份数计它包括如下成分:咖啡因2份;人参提取物5份;薄荷提取物4份;岩藻多糖10份;大豆多肽5份;猴头菇提取物3份。具体的说,薄荷提取物为薄荷油和薄荷脑。岩藻多糖的分子量为800。大豆多肽的分子量为500。
其中,咖啡因其提取工艺如下:将咖啡豆在250℃下进行焙炒并粉碎,得到熟咖啡粉;取10g咖啡粉末加入到容器中,加入40ml95%乙醇溶液浸泡1小时;微波加热5分钟;将容器内上清液倒入盛有生石灰的蒸发皿中加热,不断搅拌至粉末状,在蒸发皿上盖上一张扎有小孔的滤纸,再在上面扣一个口上塞有棉花的漏斗进行加热,使咖啡因升华,在滤纸小孔周围的针状晶体即为咖啡因,进行收集备用。
猴头菇提取物的制备方法为:将干燥的猴头菇清洗干净控干水分,掰成小块,采用2倍重量40℃的温水恒温浸泡半小时;浸泡后加热至煮沸,煮20分钟后,过滤,取滤渣加入1倍猴头菇原始重量的水继续加热至煮沸,煮30分钟后,过滤,取两次滤液合并后继续加热至煮沸,并不断搅拌,制成流浸膏备用。
本发明还提供一种防疲劳提神的复合制剂的制备工艺,它包括如下步骤:
(1)物料预处理:将咖啡因、人参提取物、岩藻多糖和大豆多肽分别进行过筛,所述的筛子为80目;
(2)称量:按照配方所述的量称取每种原料的量并单独存放;
(3)制粒:现将咖啡因、人参提取物、岩藻多糖和大豆多肽移入高效湿法制粒机中混合均匀后,加入猴头菇提取物,再次混合均匀后加入薄荷提取物混合均匀,制成颗粒;
(4)干燥:将湿颗粒移入快速整粒机分散制粒,再移入干燥制粒机中干燥,直至颗粒烘干;
(5)整粒:将干颗粒采用快速整粒机整粒,分散成均匀的颗粒;
(6)压片:将颗粒采用压片设备进行压片;
(7)包装:采用自动包装机包装,并进行装盒后再装箱,入库保存。
实施例2
一种防疲劳提神的复合制剂,按重量份数计它包括如下成分:咖啡因4份;人参提取物7份;薄荷提取物6份;岩藻多糖20份;大豆多肽10份;猴头菇提取物5份。具体的说,薄荷提取物为薄荷油和薄荷脑。岩藻多糖的分子量为1000。大豆多肽的分子量为1000。
其中,咖啡因其提取工艺如下:将咖啡豆在250℃下进行焙炒并粉碎,得到熟咖啡粉;取20g咖啡粉末加入到容器中,加入100ml95%乙醇溶液浸泡2小时;微波加热10分钟;将容器内上清液倒入盛有生石灰的蒸发皿中加热,不断搅拌至粉末状,在蒸发皿上盖上一张扎有小孔的滤纸,再在上面扣一个口上塞有棉花的漏斗进行加热,使咖啡因升华,在滤纸小孔周围的针状晶体即为咖啡因,进行收集备用。
猴头菇提取物的制备方法为:将干燥的猴头菇清洗干净控干水分,掰成小块,采用2倍重量60℃的温水恒温浸泡半小时;浸泡后加热至煮沸,煮30分钟后,过滤,取滤渣加入1倍猴头菇原始重量的水继续加热至煮沸,煮40分钟后,过滤,取两次滤液合并后继续加热至煮沸,并不断搅拌,制成流浸膏备用。
本发明还提供一种防疲劳提神的复合制剂的制备工艺,它包括如下步骤:
(1)物料预处理:将咖啡因、人参提取物、岩藻多糖和大豆多肽分别进行过筛,所述的筛子为100目;
(2)称量:按照配方所述的量称取每种原料的量并单独存放;
(3)制粒:现将咖啡因、人参提取物、岩藻多糖和大豆多肽移入高效湿法制粒机中混合均匀后,加入猴头菇提取物,再次混合均匀后加入薄荷提取物混合均匀,制成颗粒;
(4)干燥:将湿颗粒移入快速整粒机分散制粒,再移入干燥制粒机中干燥,直至颗粒烘干;
(5)整粒:将干颗粒采用快速整粒机整粒,分散成均匀的颗粒;
(6)压片:将颗粒采用压片设备进行压片;
(7)包装:采用自动包装机包装,并进行装盒后再装箱,入库保存。
实施例3
一种防疲劳提神的复合制剂,按重量份数计它包括如下成分:咖啡因3份;人参提取物6份;薄荷提取物5份;岩藻多糖15份;大豆多肽7份;猴头菇提取物4份。具体的说,薄荷提取物为薄荷油和薄荷脑。岩藻多糖的分子量为900。大豆多肽的分子量为700。
其中,咖啡因其提取工艺如下:将咖啡豆在250℃下进行焙炒并粉碎,得到熟咖啡粉;取15g咖啡粉末加入到容器中,加入70ml95%乙醇溶液浸泡1.5小时;微波加热7分钟;将容器内上清液倒入盛有生石灰的蒸发皿中加热,不断搅拌至粉末状,在蒸发皿上盖上一张扎有小孔的滤纸,再在上面扣一个口上塞有棉花的漏斗进行加热,使咖啡因升华,在滤纸小孔周围的针状晶体即为咖啡因,进行收集备用。
猴头菇提取物的制备方法为:将干燥的猴头菇清洗干净控干水分,掰成小块,采用2倍重量50℃的温水恒温浸泡半小时;浸泡后加热至煮沸,煮25分钟后,过滤,取滤渣加入1倍猴头菇原始重量的水继续加热至煮沸,煮35分钟后,过滤,取两次滤液合并后继续加热至煮沸,并不断搅拌,制成流浸膏备用。
本发明还提供一种防疲劳提神的复合制剂的制备工艺,它包括如下步骤:
(1)物料预处理:将咖啡因、人参提取物、岩藻多糖和大豆多肽分别进行过筛,所述的筛子为90目;
(2)称量:按照配方所述的量称取每种原料的量并单独存放;
(3)制粒:现将咖啡因、人参提取物、岩藻多糖和大豆多肽移入高效湿法制粒机中混合均匀后,加入猴头菇提取物,再次混合均匀后加入薄荷提取物混合均匀,制成颗粒;
(4)干燥:将湿颗粒移入快速整粒机分散制粒,再移入干燥制粒机中干燥,直至颗粒烘干;
(5)整粒:将干颗粒采用快速整粒机整粒,分散成均匀的颗粒;
(6)压片:将颗粒采用压片设备进行压片;
(7)包装:采用自动包装机包装,并进行装盒后再装箱,入库保存。
实验1
通过实施例3配方和制备方法制得的片剂进行人体实验。以青岛市内选择劳动强度大,脑力劳动多,或者需要经常熬夜的人士为实验对象,年龄为20-50岁之间,身体健康,女士未怀孕未在哺乳期,其中医院护士及医生(需经常值夜班)的30人,司机20人,企业高管10人,大学生80人,建筑工地工人20人,共计160人,每天随餐服用本发明片剂3次,每次2片,每片以0.75g计,持续服用2个月,跟踪记录实验人员的工作状态。
疗效判定标准
显著:精神状态饱满,工作或学习效率明显提高,工作或学习中条理清晰,出错率显著降低,原先头脑混沌的感觉消失,疲劳感消失,工作或学习中注意力能很快集中。
改善:精神状态优于服药前,工作或学习效率有所提高,工作或学习中能理清思路,原先头脑混沌的感觉有所减轻,疲劳感有所减轻。
无效:与服药前感觉无异。
统计结果见下表。
表1实验人员服用本发明药物后的状态记录
显著 | 有效 | 无效 | |
例数(例) | 85 | 70 | 5 |
比例(%) | 53.12 | 43.75 | 3.13 |
从上表可以看出绝大部分服药本药物后觉得精神状态良好,疲劳感消失或有所减轻,能更好的集中精神工作或学习,且无任何不适感,所以说,本药物能有效预防疲劳和提神的效果。
实验2
通过实施例3配方和制备方法制得的片剂进行人体短期快速效果实验。以青岛市每天工作时间为10-14小时的出租车司机为实验对象,年龄为20-50岁之间,身体健康,女士未怀孕未在哺乳期,共计人数69人,服用剂量为每天3-4次,每次3片,每片以0.75g计,持续服用2周,跟踪记录实验人员的工作状态。
疗效判定标准
显著:快速提神效果显著,长时间开车疲劳感较服药前减轻,精神状态饱满。
改善:有一定快速提神效果,长时间开车疲劳感较服药前有所减轻,精神状态有所改善。
无效:与服药前感觉无异。
统计结果见下表。
表2出租车司机服用本发明药物后的状态记录
显著 | 有效 | 无效 | |
例数(例) | 38 | 28 | 3 |
比例(%) | 55.07 | 40.58 | 4.35 |
从上表可以看出绝大部分服药本药物后觉得能快速提神,在长时间开车的情况疲劳感在一定程度上得到减轻,精神状态良好,且无任何不适感,所以说,本药物具有快速提神和减少疲劳感的疗效。
Claims (7)
1.一种防疲劳提神的复合制剂,其特征在于:按重量份数计它包括如下成分:咖啡因2-4份;人参提取物5-7份;薄荷提取物4-6份;岩藻多糖10-20份;大豆多肽5-10份;猴头菇提取物3-5份。
2.根据权利要求1所述的防疲劳提神的复合制剂,其特征在于:所述的咖啡因其提取工艺如下:将咖啡豆在250℃下进行焙炒并粉碎,得到熟咖啡粉;取10-20g咖啡粉末加入到容器中,加入40-100ml95%乙醇溶液浸泡1-2小时;微波加热5-10分钟;将容器内上清液倒入盛有生石灰的蒸发皿中加热,不断搅拌至粉末状,在蒸发皿上盖上一张扎有小孔的滤纸,再在上面扣一个口上塞有棉花的漏斗进行加热,使咖啡因升华,在滤纸小孔周围的针状晶体即为咖啡因,进行收集备用。
3.根据权利要求1所述的防疲劳提神的复合制剂,其特征在于:所述的薄荷提取物为薄荷油和薄荷脑。
4.根据权利要求1所述的防疲劳提神的复合制剂,其特征在于:所述的盐藻多糖的分子量为1000以内。
5.根据权利要求1所述的防疲劳提神的复合制剂,其特征在于:所述的大豆多肽的分子量为500-1000。
6.根据权利要求1所述的防疲劳提神的复合制剂,其特征在于:所述猴头菇提取物的制备方法为:将干燥的猴头菇清洗干净控干水分,掰成小块,采用2倍重量40-60℃的温水恒温浸泡半小时;浸泡后加热至煮沸,煮20-30分钟后,过滤,取滤渣加入1倍猴头菇原始重量的水继续加热至煮沸,煮30-40分钟后,过滤,取两次滤液合并后继续加热至煮沸,并不断搅拌,制成流浸膏备用。
7.根据权利要求1所述防疲劳提神的复合制剂的制备工艺,其特征在于:它包括如下步骤:
(1)物料预处理:将咖啡因、人参提取物、岩藻多糖和大豆多肽分别进行过筛,所述的筛子为80-100目;
(2)称量:按照配方所述的量称取每种原料的量并单独存放;
(3)制粒:现将咖啡因、人参提取物、岩藻多糖和大豆多肽移入高效湿法制粒机中混合均匀后,加入猴头菇提取物,再次混合均匀后加入薄荷提取物混合均匀,制成颗粒;
(4)干燥:将湿颗粒移入快速整粒机分散制粒,再移入干燥制粒机中干燥,直至颗粒烘干;
(5)整粒:将干颗粒采用快速整粒机整粒,分散成均匀的颗粒;
(6)压片:将颗粒采用压片设备进行压片;
(7)包装:采用自动包装机包装,并进行装盒后再装箱,入库保存。
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201610224563.8A CN105816850A (zh) | 2016-04-12 | 2016-04-12 | 一种防疲劳提神的复合制剂及其制备工艺 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201610224563.8A CN105816850A (zh) | 2016-04-12 | 2016-04-12 | 一种防疲劳提神的复合制剂及其制备工艺 |
Publications (1)
Publication Number | Publication Date |
---|---|
CN105816850A true CN105816850A (zh) | 2016-08-03 |
Family
ID=56525857
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201610224563.8A Pending CN105816850A (zh) | 2016-04-12 | 2016-04-12 | 一种防疲劳提神的复合制剂及其制备工艺 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN105816850A (zh) |
Cited By (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN107259365A (zh) * | 2017-07-06 | 2017-10-20 | 长沙爱扬医药科技有限公司 | 利用土人参制备多糖保健产品 |
CN110754558A (zh) * | 2018-12-22 | 2020-02-07 | 广东永青生物科技有限公司 | 一组以结晶果糖为主要能源原料制备的果糖能量咀嚼片 |
CN110771888A (zh) * | 2018-07-30 | 2020-02-11 | 云南苗晨生物科技有限公司 | 一种具有提神醒脑功能的可食用气溶胶的制备方法 |
CN114009774A (zh) * | 2021-10-15 | 2022-02-08 | 覃波 | 一种抗疲劳的组合物、饮料及其制备方法 |
Citations (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1739626A (zh) * | 2005-09-13 | 2006-03-01 | 孙景茂 | 茶提取物滴丸制剂 |
CN102150724A (zh) * | 2011-03-30 | 2011-08-17 | 姜天安 | 一种提神缓解体力和视觉疲劳的功能性混合物及其应用 |
CN102960810A (zh) * | 2012-12-05 | 2013-03-13 | 上海普维健康食品有限公司 | 玛咖饮料 |
CN103750475A (zh) * | 2013-12-04 | 2014-04-30 | 万明举 | 消除亚健康保健饮料 |
CN104026696A (zh) * | 2014-04-29 | 2014-09-10 | 陆开云 | 一种提神咖啡糯米汁 |
CN104974158A (zh) * | 2015-07-13 | 2015-10-14 | 江苏天晟药业有限公司 | 一种从茶叶中提取咖啡因的方法 |
-
2016
- 2016-04-12 CN CN201610224563.8A patent/CN105816850A/zh active Pending
Patent Citations (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1739626A (zh) * | 2005-09-13 | 2006-03-01 | 孙景茂 | 茶提取物滴丸制剂 |
CN102150724A (zh) * | 2011-03-30 | 2011-08-17 | 姜天安 | 一种提神缓解体力和视觉疲劳的功能性混合物及其应用 |
CN102960810A (zh) * | 2012-12-05 | 2013-03-13 | 上海普维健康食品有限公司 | 玛咖饮料 |
CN103750475A (zh) * | 2013-12-04 | 2014-04-30 | 万明举 | 消除亚健康保健饮料 |
CN104026696A (zh) * | 2014-04-29 | 2014-09-10 | 陆开云 | 一种提神咖啡糯米汁 |
CN104974158A (zh) * | 2015-07-13 | 2015-10-14 | 江苏天晟药业有限公司 | 一种从茶叶中提取咖啡因的方法 |
Cited By (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN107259365A (zh) * | 2017-07-06 | 2017-10-20 | 长沙爱扬医药科技有限公司 | 利用土人参制备多糖保健产品 |
CN110771888A (zh) * | 2018-07-30 | 2020-02-11 | 云南苗晨生物科技有限公司 | 一种具有提神醒脑功能的可食用气溶胶的制备方法 |
CN110754558A (zh) * | 2018-12-22 | 2020-02-07 | 广东永青生物科技有限公司 | 一组以结晶果糖为主要能源原料制备的果糖能量咀嚼片 |
CN114009774A (zh) * | 2021-10-15 | 2022-02-08 | 覃波 | 一种抗疲劳的组合物、饮料及其制备方法 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN104041644B (zh) | 润肠茶及其制备方法 | |
CN101253917B (zh) | 一种八月札保健茶 | |
CN105816850A (zh) | 一种防疲劳提神的复合制剂及其制备工艺 | |
CN106110282A (zh) | 一种调理脾虚的中药组合物 | |
CN102920806B (zh) | 安神降压中药茶 | |
CN103519267A (zh) | 一种蜂蜜醋保健饮料及其制作方法 | |
CN103283900B (zh) | 中药保健茶 | |
CN103300197B (zh) | 一种助眠茶及其制作方法 | |
CN106389587A (zh) | 一种清润保健花茶及其制备工艺 | |
CN101253911A (zh) | 一种回心草保健茶 | |
CN103478821B (zh) | 一种保健饮料及其生产工艺 | |
CN104474251B (zh) | 具有健脑固本功能的组合物及其制剂和应用 | |
CN102125632A (zh) | 防治高血压的中药保健茶 | |
CN107969696A (zh) | 一种柚子醒酒膏 | |
CN103340252A (zh) | 四季茶强身保健饮料 | |
CN103750425B (zh) | 一种高丽红参罗汉果汤的制备方法 | |
CN102018071A (zh) | 防治高血压的中药保健茶 | |
CN102835700A (zh) | 具有润肺、养胃功效的保健饮料及其制作方法 | |
CN103315085B (zh) | 一种养生茶 | |
CN103961627A (zh) | 一种铁皮石斛中药醒酒膏 | |
CN103798472A (zh) | 一种保健茶及保健养生制剂 | |
CN102886011A (zh) | 一种治疗消化不良的中药 | |
CN103445248A (zh) | 一种健胃消食保健饮品的制备方法 | |
CN102224894B (zh) | 当归养生酒及其制备方法 | |
CN106421173A (zh) | 一种供顽固性头痛患者食用的保健食品及其制备方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
RJ01 | Rejection of invention patent application after publication |
Application publication date: 20160803 |
|
RJ01 | Rejection of invention patent application after publication |